跳至主要内容
临床试验/DRKS00025694
DRKS00025694已完成不适用

Covid-19 Vaccination in Patients with Inflammatory Bowel Diseases - CoVac IBD

Medizinische Hochschule Hannover0 个研究点目标入组 23 人开始时间: 2021年6月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Male and female patients aged =18 years
  • - History of inflammatory bowel disease (>3 months)
  • - IBD patients prior to Covid-19 vaccination
  • - Written informed consent from the patient

排除标准

  • - Conditions that do not allow the subject to appreciate the nature, scope, and possible consequences of the clinical trial.
  • - Indications that the patient is unlikely to comply with the protocol (e.g., unwillingness to cooperate)
  • - Covid-19 vaccination already administered.

研究者

发起方
Medizinische Hochschule Hannover

相似试验

Covid-19 Vaccination in Patients with Inflammatory... | 临床试验